Class information for:
Level 1: AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
122 4188 36.6 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
390 16316 MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMLODIPINE Author keyword 29 15% 4% 175
2 BLOOD PRESSURE CONTROL Author keyword 25 23% 2% 97
3 ANTIHYPERTENSIVE THERAPY Author keyword 25 18% 3% 128
4 ANTIHYPERTENSIVE TREATMENT Author keyword 23 19% 3% 108
5 HYDROCHLOROTHIAZIDE Author keyword 23 15% 3% 139
6 TARGET BLOOD PRESSURE Author keyword 21 61% 1% 23
7 BLOOD PRESSURE LOWERING Author keyword 21 55% 1% 26
8 INDAPAMIDE Author keyword 21 29% 1% 61
9 SINGLE PILL COMBINATION Author keyword 20 67% 0% 18
10 J CURVE Author keyword 19 41% 1% 37

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 AMLODIPINE 29 15% 4% 175 Search AMLODIPINE Search AMLODIPINE
2 BLOOD PRESSURE CONTROL 25 23% 2% 97 Search BLOOD+PRESSURE+CONTROL Search BLOOD+PRESSURE+CONTROL
3 ANTIHYPERTENSIVE THERAPY 25 18% 3% 128 Search ANTIHYPERTENSIVE+THERAPY Search ANTIHYPERTENSIVE+THERAPY
4 ANTIHYPERTENSIVE TREATMENT 23 19% 3% 108 Search ANTIHYPERTENSIVE+TREATMENT Search ANTIHYPERTENSIVE+TREATMENT
5 HYDROCHLOROTHIAZIDE 23 15% 3% 139 Search HYDROCHLOROTHIAZIDE Search HYDROCHLOROTHIAZIDE
6 TARGET BLOOD PRESSURE 21 61% 1% 23 Search TARGET+BLOOD+PRESSURE Search TARGET+BLOOD+PRESSURE
7 BLOOD PRESSURE LOWERING 21 55% 1% 26 Search BLOOD+PRESSURE+LOWERING Search BLOOD+PRESSURE+LOWERING
8 INDAPAMIDE 21 29% 1% 61 Search INDAPAMIDE Search INDAPAMIDE
9 SINGLE PILL COMBINATION 20 67% 0% 18 Search SINGLE+PILL+COMBINATION Search SINGLE+PILL+COMBINATION
10 J CURVE 19 41% 1% 37 Search J+CURVE Search J+CURVE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ISOLATED SYSTOLIC HYPERTENSION 254 34% 15% 609
2 SWEDISH TRIAL 142 77% 2% 98
3 ANTIHYPERTENSIVE DRUG TREATMENT 114 65% 3% 108
4 LIPID LOWERING TREATMENT 104 37% 5% 227
5 ACTIVE TREATMENT 100 57% 3% 120
6 CALCIUM CHANNEL BLOCKER 83 28% 6% 248
7 FIXED DOSE COMBINATIONS 76 66% 2% 70
8 MAJOR CARDIOVASCULAR EVENTS 74 53% 2% 99
9 PROSPECTIVELY DESIGNED OVERVIEWS 65 52% 2% 87
10 CARDIOVASCULAR MORBIDITY 58 26% 5% 195

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF CLINICAL HYPERTENSION 13 12% 3% 105
2 BLOOD PRESSURE 12 11% 2% 102
3 AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 4 10% 1% 36

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) 2014 712 28 75%
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document 2009 614 252 38%
2013 ESH/ESC Guidelines for the management of arterial hypertension 2013 518 655 17%
2007 guidelines for the management of arterial hypertension 2007 2620 687 18%
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 2003 5625 283 21%
Chlorthalidone Compared With Hydrochlorothiazide in Reducing Cardiovascular Events Systematic Review and Network Meta-Analyses 2012 43 38 66%
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1997 3942 183 20%
Effects of Blood Pressure Reduction in Mild Hypertension A Systematic Review and Meta-analysis 2015 5 29 41%
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal 2009 86 50 76%
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials 2011 51 33 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARL EDYTH LINDNER EDUC 9 55% 0.3% 11
2 BLOOD P SURE LOWERING TREATMENT TRIALISTS A 8 100% 0.1% 5
3 FISIOL CLIN IPERTENS 8 18% 1.0% 41
4 PROG S ABORAT GRP 7 64% 0.2% 7
5 HYPERTENS CARDIOVASC REHABIL UNIT 7 17% 0.9% 38
6 HYPERTENS DIS SECT 5 42% 0.2% 10
7 PRIMARY CARE SERV LINE 5 47% 0.2% 8
8 UNIDAD HIPERTENS 4 17% 0.6% 24
9 HIGH BLOOD P SURE EDUC PROGRAM 4 47% 0.2% 7
10 DOUALA CARDIOVASC 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000209318 PULSE PRESSURE//PSEUDOHYPERTENSION//PENAZ METHOD
2 0.0000188704 PREHYPERTENSION//HYPERTENSION PREVALENCE//HIGH NORMAL BLOOD PRESSURE
3 0.0000152965 MRC TRIAL//ABORAT PREVENT TREATMENT CARDIOVASC DIS//CLIN EPIDEMIOL HLTH CARE PROGRAM MED
4 0.0000150344 TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY
5 0.0000140664 LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE
6 0.0000106018 INTEGRATED CARDIOVASC CLIN NETWORK SA//PREVENTAT HLTH//ANGIOTENSIN CONVERTING ENZYME INHIBITOR THERAPY
7 0.0000096673 CANDESARTAN CILEXETIL//ANGIOTENSIN II RECEPTOR ANTAGONIST//LOSARTAN
8 0.0000091755 DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE
9 0.0000088174 INDAPAMIDE//CLIN NUTR METAB DIS//PHARMACOL PHYSIOPATHOL CARDIOVASC
10 0.0000087901 AMLODIPINE//DILTIAZEM CR//BESYLATE